A Review of Neuro-Ophthalmological Manifestations of Human Coronavirus Infection

Abstract

Introduction

Human coronavirus (HCoVs) are a group of viruses with recognized neurotropic and neuroinvasive capabilities. The reports on the neurological and ocular findings are increasing day after day and several central and peripheral neurological manifestations are already described. However, none specifically describes the neuro-ophthalmological manifestation of HCoVs. This is the first article specifically reviewing neuro-ophthalmological manifestations of HCoVs infection.

Methods

PubMed and Google Scholar databases were searched using the keywords: coronaviridae, coronavirus, COVID-19, SARS-CoV-2, SARS-CoV-1, MERS, ocular, ophthalmology, ophthalmological, neuro-ophthalmology, neurological, manifestations. A manual search through the reference lists of relevant articles was also performed. There were no restrictions concerning language or study type and publications not yet printed but available online were considered.

Results

Coronavirus eye involvement is not frequent and includes mostly a typical viral follicular conjunctivitis. Recently, retinal anatomical alterations were described using optic coherence tomography. Neuro-ophthalmological symptoms and signs can appear isolated or associated with neurological syndromes. The manifestations include headache, ocular pain, visual impairment, diplopia, and cranial nerve palsies secondary to Miller Fisher syndrome, Guillain-Barré syndrome, or encephalitis, and nystagmus.

Conclusion

Neurological and neuro-ophthalmological syndromes, symptoms, and signs should not be neglected and a complete ophthalmological examination of these patients should be performed to fully describe ocular manifestations related to HCoVs. We believe that major ocular and neuro-ophthalmological manifestations reports lack due to safety issues concerning detailed ophthalmological examination; on the other hand, in a large number of cases, the presence of life-threatening coronavirus disease hinders ocular examination and ophthalmologist’s visit to the intensive care unit.

Keywords:

• human coronavirus
• neurotropic
• neuro-ophthalmological
• ophthalmology
• manifestations

Introduction

Coronaviridae is a family of enveloped positive-strand RNA viruses that infect vertebrates and is currently constituted by 2 subfamilies, 5 genera, 26 subgenera, and 46 species.^1–3

Seven coronaviruses (CoV) species are known to cause infections in humans – 229E (alphacoronavirus), NL63 (alphacoronavirus), OC43 (betacoronavirus), HKU1 (betacoronavirus) - the majority being responsible for mild upper respiratory disease. On the other hand, severe acute respiratory syndrome-related coronavirus-1 (SARS-CoV-1), and Middle East respiratory syndrome-related coronavirus (MERS-CoV) can cause severe respiratory distress, enteric and neurological disease with a mortality rate ranging from 10% to 36%.^4,5 More recently, severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2), also known as Coronavirus Disease 2019 (COVID-19), is responsible for affecting 5.105.881 people and causing 333.446 deaths in 216 countries, according to data reported on 23rd May 2020 by the World Health Organization.⁶ Despite these representative numbers, non-respiratory clinical manifestations of the disease, namely ophthalmological and neuro-ophthalmological manifestations, are still not widely and well described. We believe this is partly due to the technical and safety issues concerning the detailed ophthalmological examinations of these patients and the legitimate tendency to neglect eye complaints at the expense of life-threatening manifestations.⁷

Neurotropic and neuroinvasive capabilities of coronaviruses have been described in humans. It is proposed that coronavirus can reach and infect the central nervous system by several paths. Some suggested pathways include the hematogenous or lymphatic route, in which persistently infected leukocytes serve as reservoir and vector to Central Nervous System (CNS) infection and transneuronal retrograde dissemination following nasal infection and olfactory bulb involvement.^8,9 The human host cell infection pathway is mediated by the angiotensin-converting enzyme 2 receptor for SARS-CoV-1 and SARS-CoV-2^10,12 which proved to be present in the aqueous humor¹³ but not in other parts of the eye.

This review article aims to describe the neuro-ophthalmological manifestations of human coronavirus (HCoV) infection. To date, this is the first article specifically reviewing this issue.

Methods

The authors searched PubMed/Medline and Google Scholar database using the following keywords: coronaviridae, coronavirus, COVID-19, Sars-Cov-2, Sars-Cov-1, MERS, ocular, ophthalmology, ophthalmological, neuro-ophthalmology, neurological, manifestations. The relevant articles were identified through the title and abstract information. The authors also performed a manual search through the reference lists of relevant articles. There were no restrictions concerning language or study type. Publications not yet printed but available online were considered. The literature review was last done on 23rd May 2020. The study flow diagram is represented in Figure 1.

Figure 1 PRISMA flow diagram.

Notes: Adapted from Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7). doi:10.1371/journal.pmed.1000097. Creative Commons.¹⁴

Ocular Non-Neuro-Ophthalmological Manifestations

Conjunctivitis and Keratoconjunctivitis

A report from Hubei Province in China reported 31.6% of ocular manifestations in COVID-19 patients consisting of chemosis, epiphora, conjunctival hyperemia, and secretion. Of these 12 patients, 11 had a positive nasopharyngeal swab but only two had a positive nasopharyngeal and conjunctival swab. One patient developed conjunctivitis as the first manifestation of the disease. The presence of eye symptoms appears to be associated with more severe analytical alterations such as higher white blood cell and neutrophil count, high C-reactive protein, lactate dehydrogenase, and procalcitonin levels.¹⁵ This fact suggests that ocular manifestations are associated with more severe disease.

Itching, foreign body sensation, dry eyes, and floaters were also described symptoms during the course of COVID-19,^16,17 as well as pseudomembranous and hemorrhagic conjunctivitis.¹⁸

In another case series, Jianhua Xia et al described that one in 30 patients (3.3%) presented with conjunctivitis three days after disease onset, consisting of conjunctival hyperemia and aqueous secretion. Only this patient had a positive conjunctival swab for SARS-CoV-2.¹⁹ No further ocular or neuro-ophthalmological manifestations were reported.

We only found two papers describing COVID-19 patients with external ocular signs of viral infection that were fully examined with a slit lamp and fundoscopic exam by an ophthalmologist.^20,21 The first case reports a patient with ocular signs of infection 13 days after disease onset. A classic follicular conjunctivitis with a palpable preauricular lymph node and no subconjunctival hemorrhage or pseudomembrane was observed. Fundoscopic examination and macular structure and thickness analysis by optical coherence tomography (OCT) were normal.²⁰ No structural or functional imaging of the optic nerve was performed. The other case describes a keratoconjunctivitis as the initial presentation of COVID-19 with conjunctival follicular reaction and corneal subepithelial infiltrates.²¹

Concerning the other HCoVs, polymerase chain reaction (PCR) of patient’s tears with SARS-CoV-1 demonstrated the presence of the virus during the global outbreak in 2003 but no clinical ocular manifestations were described.²² Another human coronavirus, the HCoV NL63, was associated with conjunctivitis in a seven-month-old child.²³

HCoV infection can cause a typical viral follicular conjunctivitis with or without pseudomembrane development that appears in the majority of patients after disease onset but can be the inaugural or the only manifestation^15,24–26 of the disease.

Uveitis, Retinitis and Retinal Anatomical Alterations

Coronaviruses are capable of causing anterior uveitis, choroiditis, vasculitis, and retinitis in animals²⁷ but these manifestations have not been described in humans. However, recently Paula Marinho et al in a study published on 12th May 2020 assessing the retina of 12 patients with COVID-19 found cotton wool spots and retinal hemorrhages on the fundus of four patients, and bilateral hyperreflective lesions in the ganglion cell and inner plexiform layers of all 12 patients using OCT.²⁸ Despite these lesions being more prominent at the papillomacular bundle, the visual acuity was normal.

Ocular non-neuro-ophthalmological manifestations of patients infected with HCoVs are represented in Table 1.

Table 1 Ocular Non-Neuro-Ophthalmological Manifestations of Patients Infected with HCoVs

Study	Virus	Study Type	Sample Size	Ocular Non Neuro-Ophthalmological Manifestations
Van Der Hoek L et al 2004^Citation23	HCoV NL63	Case report	One	Conjunctivitis
Wu P. et al. 2019^Citation15	SARS-CoV-2	Case series	38 total 12 with ocular manifestations	Conjunctivitis characterized by chemosis, epiphora, conjunctival hyperemia and secretion; Two Positive conjunctival swab
Xia et al 2020^Citation19		Prospective interventional case series	30 total One with ocular manifestations	Conjunctival hyperemia, aqueous secretion; Positive conjunctival swab
Navel V. et al 2020^Citation18		Case report	One	Conjunctival hyperemia, secretion, follicles, petechiae, tarsal hemorrhages, chemosis, punctuate keratitis superficial punctuate keratitis, pseudomembranous tarsal reaction
Zhou Y. et al 2020^Citation16		Cross sectional	121 total Eight with ocular symptoms	Itching, redness, tearing, discharge, foreign body sensation; Positive conjunctival swab (1)
Hong N. et al 2020^Citation17		Cross sectional	56 total 15 with ocular symptoms	Eye pain, itching, foreign body sensation, tearing, redness, dry eyes, eye secretions, floaters
Chen L. et al 2020^Citation20		Case report	One	Follicular conjunctivitis, palpable preauricular lymph node
Cheema M et al 2020^Citation21		Case report	One	Keratoconjunctivitis, conjunctival follicular reaction and corneal subepithelial infiltrates
Marinho P. et al 2020^Citation28		Cross sectional	12	Cotton wool spots, retinal hemorrhages, bilateral hyper-reflective lesions in ganglion cell and inner plexiform layers
Daruich A. et al 2020^Citation24		Case report	One	Foreign body sensation, eyelid edema, conjunctival hyperemia; Intense headache*
Sirakaya E. et al 2020^Citation26		Case report	One	Bilateral acute follicular conjunctivitis; Positive conjunctival swab

Notes: *We considered these symptoms/signs as part of neuro-ophthalmological manifestations. The numbers in parentheses represent the number or percentage of patients who presented with the symptom and/or sign.

Abbreviations: HCoVs, human coronavirus; SARS-CoV-2, severe acute respiratory syndrome-related coronavirus-2;

Neuro-Ophthalmological Manifestations

Few studies have reported that human coronavirus may be associated with CNS involvement, namely acute encephalitis-like syndrome, acute disseminated encephalomyelitis, and multiple sclerosis.^29–35 In animal models, CoVs have been related to an immune-mediated process of chronic demyelination of the CNS.³³ Despite the few associations between coronavirus and demyelinating disease, this effect in humans has not been directly proved and the association between these two entities is controversial.

Concerning the recent SARS-CoV-2, the reports on the neurological findings are increasing day after day and several central and peripheral neurological manifestations are already described such as dizziness, headache, seizures, changes in mental status, ataxia, acute cerebrovascular disease, CNS vasculitis, posterior reversible encephalopathy syndrome, acute necrotizing myelitis, encephalitis and taste and smell impairment.^36–44 Associations with demyelinating diseases like Miller Fisher syndrome and Guillain-Barré syndrome were also described.^45–49 Regardless of the increasing number of published data, none describes the specific neuro-ophthalmological manifestation of HCoVs.

The physiopathology of neurological involvement is still not fully understood. One of the theories suggests that coronavirus is a neurotrophic and neuroinvasive virus and that hypogeusia and anosmia are manifestations of peripheral nervous systems involvement and a way of infection into the nervous system.^11,50 Since the central and peripheral nervous system can be affected, we believe that neuro-ophthalmological manifestations can occur.

Neuro-ophthalmological manifestations of patients infected with HCoVs are represented in Table 2.

Table 2 Neuro-Ophthalmological Manifestations of Patients Infected with HCoVs

Study	Virus	Study Type	Sample Size	Neuro-Ophthalmological Manifestations
Li Y. et al 2017^Citation29	Coronavirus	Cross sectional	414 total 183 with acute encephalitis-like syndrome	Headache (45.5%) secondary to encephalitis-like syndrome
Kim JE. et al 2017^Citation51	MERS-CoV	Retrospective	23 total Four with neurological complications	Ptosis and external ophthalmoplegia (Bickerstaff encephalitis + Guillain Barré syndrome)
Huang C. et al 2020^Citation52	SARS-CoV-2	Prospective	41	Headache (3)
Li R. et al 2020^Citation53		Retrospective	225	Headache
Zheng Y. 2020^Citation54		Retrospective	73	Headache (1.4%)
Tostmann A. et al 2020^Citation55		Cohort study	803 total 90 with SARS-CoV-2-positive	Ocular pain (31), headache (64)
Mao L. et al 2020^Citation37		Retrospective observational case series	214	Visual impairment (3), headache (28)
Dinkin M. et al 2020^Citation45		2 Case reports	Two	Diplopia, nystagmus, incomplete left third nerve palsy and pupillary involvement, bilateral sixth nerve palsy (Miller Fisher syndrome) Diplopia, nystagmus, isolated sixth nerve palsy
Gutiérrez-Ortiz C. et al 2020^Citation56		2 Case reports	Two	Headache, diplopia, internuclear ophthalmoparesis, nystagmus, third nerve palsy (Miller Fisher Syndrome) Diplopia, esotropia, bilateral abducents palsy, fixation nystagmus (polyneuritis cranialis)
Juliao Caamaño D et al 2020^Citation46		Case report	One	Facial diplegia with incomplete blink
Pellitero SE. 2020^Citation57		Case report	One	Nystagmus secondary to an acute vestibular dysfunction
Xiang P. 2020^Citation58		Case report	One	Slow pupillary responses secondary to encephalitis

Notes: The numbers in parentheses represent the number or percentage of patients who presented with the symptom and/or sign.

Abbreviations: HCoVs, human coronavirus; MERS-CoV, Middle East respiratory syndrome-related coronavirus; SARS-CoV-2, severe acute respiratory syndrome-related coronavirus-2.

Headache, Ocular or Periocular Pain

Headache has been reported as a major clinical symptom with 1.4% to 34% of COVID-19 patients and 71.1% healthcare workers with positive SARS-CoV-2 mentioning this symptom.^{36,37,40,53–52} It is described as a pulsatile de novo headache, located over the temporoparietal region, the forehead or the periorbital region, relapsing and resistant to common-use analgesics.⁵⁹ Neuro-ophthalmological signs associated with this prevalent symptom were not described to date.

Ocular pain has also been reported and associated with SARS-CoV2 test positivity, along with headache, anosmia, myalgia, general malaise, tiredness and fever.⁵⁵

Pathophysiology of this symptom is still not fully understood. It appears to be associated with an increase of proinflammatory cytokines and a direct or indirect activation of the trigeminal nerve, rather than a direct COVID-19 CNS infection.⁵⁹ Regardless, when its development emerges associated with other neurological symptoms and signs, meningitis or encephalitis should be suspected as well other neurological syndromes.^36–39

Visual Impairment

Visual impairment was described in three of 214 COVID-19 patients (1.4%) in Wuhan³⁷ but the characteristics of vision loss such as onset, laterality, evolution, associated symptoms, and etiology were not reported. A lack of ophthalmological observation was also noted. This symptom along with hypogeusia, anosmia, and nerve pain constituted the peripheral nerve system manifestation of COVID-19 in the referred study.

Diplopia, Ophthalmoplegia and Ocular Cranial Nerves Palsy

Marc Dinkin et al described two cases of Sars-CoV-2 patients presented with diplopia and ophthalmoparesis.⁴⁵ The first is a 36-year-old man with an incomplete left third nerve palsy with pupillary involvement and a bilateral sixth nerve palsy associated with other neurologic symptoms. A diagnosis of Miller Fisher syndrome was presumed. The other case is a 71-year-old woman with an isolated right sixth nerve palsy that gradually improved two weeks later. In both cases, imaging of the CNS revealed an enhancement of the optic nerve sheaths and/or nerve enlargement and the lumbar puncture was normal for the second case.

Other cases of Miller Fisher syndrome and polyneuritis cranialis were reported by Gutiérrez-Ortiz et al.⁵⁶ Among other neurological signs, the patients presented with diplopia, afferent pupillary defect, internuclear ophthalmoparesis, and incomplete oculomotor palsy in the Miller Fisher syndrome case and esotropia and bilateral abducens palsy in the polyneuritis cranialis case. Multiple cranial neuritis involving the III and VI oculomotor nerves was also described through magnetic resonance imaging (MRI) in a patient diagnosed with Guillain-Barré syndrome associated with COVID-19, although no ocular movements disturbances were clinically described on the paper.⁶¹

Concerning MERS-CoV, a complete external ophthalmoplegia and mild limb ataxia were observed in a patient diagnosed with Bickerstaff’s encephalitis and Guillain-Barré syndrome.⁵¹

These reports provide an association between demyelinating disease and coronavirus. Cranial nerve involvement shown by CNS imaging suggests an inflammatory process/neuritis in which etiology is still unknown. Either a para-infectious, direct infection or demyelinating immune-mediated process can be speculated.

Peripheral Facial Nerve Palsy with Incomplete Blink

A progressive bilateral facial nerve palsy with unresponsive blink reflex was described in a 61-year-old patient with a facial diplegia presumed to be a variant of Guillain-Barré syndrome.⁴⁶ Complete ophthalmological examination was not performed in this patient, so other ocular manifestations of seventh nerve palsy such as lagophthalmos, upper eyelid retraction, lower eyelid ectropion, and dry eye are not known.

Other reports of Guillain-Barré syndrome in COVID-19 patients do not state ocular manifestations associated with facial weakness.^47,62–66

Nystagmus

Nystagmus was described as a sign of internuclear ophthalmoparesis in a SARS-CoV-2 patient who acutely presented with Miller Fisher syndrome and in a patient with bilateral abducens palsy.⁵⁶ In these patients, the optic disc examination was normal without optic disc edema.

Another case of horizontal nystagmus in a COVID-19 patient without respiratory symptoms was published. Pellitero et al described a case of a patient with a previous history of anosmia and ageusia three weeks before, that was observed for disequilibrium, nausea, and vomiting. Physical examination revealed horizontal nystagmus with a rapid phase to the right that worsens in dextroversion and oscilloscopy. Imaging of the CNS including MRI was normal. An acute vestibular dysfunction secondary to SARS-CoV-2 infection was the presumed diagnosis.⁵⁷

Pupillary Defects

Pupillary defects are reported in COVID-19 patients with Miller Fisher syndrome⁴⁵ due to oculomotor nerve involvement. Slow pupillary response was also described in a case of COVID-19 with encephalitis.⁵⁸

Optic Neuritis and Other Optic Disc Changes

Optic neuritis and chronic demyelination of the CNS were successfully demonstrated in animal coronavirus models.^27,33 In humans, demyelinating disease such as acute disseminated encephalomyelitis, Miller Fisher syndrome, and Guillain-Barré syndrome was also described.^30,45,46 Associations between human coronavirus and multiple sclerosis are proposed and stated in the literature as an environmental factor.^31–34 To date, there are no data demonstrating optic neuritis secondary to a HCoV infection in humans or HCoV demyelinating process.

Recently, an association between SARS-CoV-2 and a higher incidence of a severe Kawasaki disease was reported.⁶⁷ Although Kawasaki disease can exhibit ocular and manifestations such as conjunctival hyperemia, uveitis, vitreous opacities, and papilledema, none of these alterations were described in this study. Nevertheless, ocular symptoms and signs should be monitored.

Study Limitations and Strengths

There may be some possible limitations in this study. The current topic is very recent and specific information about neuro-ophthalmological manifestation is still scarce. Most of the published information consist of clinical cases or small case series, which makes generalization difficult. On the other hand, exponential published new data are available every-day and we believe that in the future there will be a better knowledge of the characteristics of human coronavirus, allowing a more solid and non-hypothetical base of knowledge.

To date, this is the first article reviewing neuro-ophthalmological manifestations of human coronavirus.

Conclusion

Human coronavirus can affect the central and peripheral nervous system; thus, neurological and neuro-ophthalmological syndromes, symptoms and signs should not be neglected. Complete ophthalmological examination of these patients should be performed to fully describe ocular manifestations related to HCoVs. The few data published consisting of small sample sizes studies, case series or isolated case reports preclude strong associations between these viruses and neurological and ophthalmological syndromes. We believe that major ocular and neuro-ophthalmological manifestations reports lack due to safety issues concerning detailed ophthalmological examination; on the other hand, in a large number of cases, the presence of life-threatening coronavirus disease hinders ocular examination and ophthalmologist’s visit to the intensive care unit.

Acknowledgments

The authors thank Dr Inês Albano, Family Medicine Doctor at Unidade de Cuidados Personalizados de Lagoa, for her contribution reviewing this manuscript.

Disclosure

There are no financial conflicts of interest to disclose. The authors report no conflicts of interest for this work.

Additional information

Funding

There is no funding to report.